Abbisko Cayman Employees

Abbisko Cayman had 276 employees as of December 31, 2025. The number of employees decreased by 5 or -1.78% compared to the previous year.

Employees

276

Change (1Y)

-5

Growth (1Y)

-1.78%

Revenue / Employee

2.47M HKD

Profits / Employee

222.75K HKD

Market Cap

6.71B

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	276	-5	-1.78%
Dec 31, 2024	281	23	8.91%
Dec 31, 2023	258	8	3.20%
Dec 31, 2022	250	90	56.25%
Dec 31, 2021	160	-	-

Company Name	Employees
Shanghai Haohai Biological Technology	2,110
Alphamab Oncology	498
Lepu Biopharma	710
CStone Pharmaceuticals	136
Suzhou Ribo Life Science	407
CARsgen Therapeutics Holdings	355
CK Life Sciences Int'l., (Holdings)	1,920
Everest Medicines	812